JPH 203

Drug Profile

JPH 203

Alternative Names: JPH-203SBECD; JPH203

Latest Information Update: 19 Feb 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator J-Pharma
  • Class Antineoplastics
  • Mechanism of Action Amino acid transport system L inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Phase I Solid tumours

Most Recent Events

  • 19 Feb 2015 JPH 203 has patent protection in Japan
  • 19 Jan 2015 Phase-I clinical trials in Solid tumours (Metastatic disease) in Japan (IV) (UMIN000016546)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top